PD-L1 binding peptide identified by phage peptide display inhibits PD-1/PD-L1 interaction and activates T cells

被引：0
|
作者：
Gurung, Smriti [1 ]
Khan, Fatima [1 ]
Lee, Soo-Woong [1 ]
Yoon, Jaewon [1 ]
Lee, Byungheon [1 ]
机构：
[1] Kyungpook Natl Univ, Daegu, South Korea
来源：
CANCER RESEARCH | 2018年 / 78卷 / 13期
关键词：
D O I：
10.1158/1538-7445.AM2018-1000
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1000
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Determination of PD-L1 positive CETCs as a biomarker for PD-1/PD-L1 treatment monitoring
    Pizon, M.
    Schott, D.
    Pachmann, U.
    Pachmann, K.
    ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 : 89 - 89
  • [32] Therapeutic PD-L1 antibodies are more effective than PD-1 antibodies in blocking PD-1/PD-L1 signaling
    Annika De Sousa Linhares
    Claire Battin
    Sabrina Jutz
    Judith Leitner
    Christine Hafner
    Joshua Tobias
    Ursula Wiedermann
    Michael Kundi
    Gerhard J. Zlabinger
    Katharina Grabmeier-Pfistershammer
    Peter Steinberger
    Scientific Reports, 9
  • [33] Therapeutic PD-L1 antibodies are more effective than PD-1 antibodies in blocking PD-1/PD-L1 signaling
    Linhares, Annika De Sousa
    Battin, Claire
    Jutz, Sabrina
    Leitner, Judith
    Hafner, Christine
    Tobias, Joshua
    Wiedermann, Ursula
    Kundi, Michael
    Zlabinger, Gerhard J.
    Grabmeier-Pfistershammer, Katharina
    Steinberger, Peter
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [34] PD-L1 Nanobody Competitively Inhibits the Formation of the PD-1/PD-L1 Complex: Comparative Molecular Dynamics Simulations
    Sun, Xin
    Yan, Xiao
    Zhuo, Wei
    Gu, Jinke
    Zuo, Ke
    Liu, Wei
    Liang, Li
    Gan, Ya
    He, Gang
    Wan, Hua
    Gou, Xiaojun
    Shi, Hubing
    Hu, Jianping
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2018, 19 (07)
  • [35] Utility of PD-L1 immunohistochemistry assays for predicting PD-1/PD-L1 inhibitor response
    Laurence P. Diggs
    Eddy C. Hsueh
    Biomarker Research, 5
  • [36] Highly Activated PD-1/PD-L1 Pathway in Gastric Cancer with PD-L1 Expression
    Saito, Hiroaki
    Kono, Yusuke
    Murakami, Yuki
    Shishido, Yuji
    Kuroda, Hirohiko
    Matsunaga, Tomoyuki
    Fukumoto, Yoji
    Osaki, Tomohiro
    Ashida, Keigo
    Fujiwara, Yoshiyuki
    ANTICANCER RESEARCH, 2018, 38 (01) : 107 - 112
  • [37] Utility of PD-L1 immunohistochemistry assays for predicting PD-1/PD-L1 inhibitor response
    Diggs, Laurence P.
    Hsueh, Eddy C.
    BIOMARKER RESEARCH, 2017, 5
  • [38] PD-L1 and PD-L2 differ in their molecular mechanisms of interaction with PD-1
    Ghiotto, Marguerite
    Gauthier, Laurent
    Serriari, Nacer
    Pastor, Sonia
    Truneh, Alemseged
    Nunes, Jacques A.
    Olive, Daniel
    INTERNATIONAL IMMUNOLOGY, 2010, 22 (08) : 651 - 660
  • [39] Expression regulation and function of PD-1 and PD-L1 in T lymphoma cells
    Liu, Maria Y.
    Klement, John D.
    Langan, Candace J.
    Riggelen, Jan van
    Liu, Kebin
    CELLULAR IMMUNOLOGY, 2021, 366
  • [40] Increase of cells expressing PD-1 and PD-L1 and enhancement of IFN- production via PD-1/PD-L1 blockade in bovine mycoplasmosis
    Goto, Shinya
    Konnai, Satoru
    Okagawa, Tomohiro
    Nishimori, Asami
    Maekawa, Naoya
    Gondaira, Satoshi
    Higuchi, Hidetoshi
    Koiwa, Masateru
    Tajima, Motoshi
    Kohara, Junko
    Ogasawara, Satoshi
    Kato, Yukinari
    Suzuki, Yasuhiko
    Murata, Shiro
    Ohashi, Kazuhiko
    IMMUNITY INFLAMMATION AND DISEASE, 2017, 5 (03) : 355 - 363
12345